Akụkọ ụlọ ọrụ
Ịdị ogologo oge nke CD19 CAR T-Cell Therapy na Ịgwọ Ọrịa Leukemia Akwụghachighachi/Na-egbochi Ọrịa Ọrịa Lymphoblastic
Nnyocha dị egwu na-egosi ọganihu ogologo oge nke CD19 CAR T-cell therapy n'ịgwọ ndị ọrịa na-arịa ọrịa leukemia na-emegharị azụ / refractory nnukwu lymphoblastic leukemia (ALL) na-esote allogeneic hematopoietic stem cell transplantation, na-enye olileanya ọhụrụ na hematology.
Ọganiihu na-aga n'ihu na cell Killer (NK) karịrị afọ 50
N'ime iri afọ ise gara aga, nyocha na mkpụrụ ndụ Natural Killer (NK) agbanweela nghọta anyị banyere ihe mgbochi ebumpụta ụwa, na-enye ụzọ ọhụrụ na-ekwe nkwa maka ọrịa kansa na ọgwụgwọ nje.
Ọganihu n'ọrịa ụmụaka autoimmune: CAR-T Cell Therapy na-agwọ onye ọrịa Lupus
Ọmụmụ ihe ọmụmụ ọsụ ụzọ na Ụlọ Ọgwụ Mahadum Erlangen na-agwọ otu nwa agbọghọ dị afọ 16 nke nwere ọrịa lupus erythematosus siri ike (SLE) nke ọma site na iji ọgwụgwọ cell CAR-T. Nke a bụ akara izizi eji ọgwụgwọ a maka lupus ụmụaka, na-enye olileanya ọhụrụ maka ụmụaka nwere ọrịa autoimmune.
Ịkwalite ịdị irè nke PROTAC: Ọmụmụ ihe na-akụda ala
Nnyocha e mere n'oge na-adịbeghị anya na Nkwukọrịta Nature na-ekpughe nghọta ndị bụ isi n'ime ụzọ mgbama dị n'ime nke na-agbanwe ịdị irè nke mmebi protein ezubere iche site na iji PROTAC. Nchọpụta a nwere ike imeghe ụzọ maka ọgwụgwọ dị irè maka ọrịa kansa na ọrịa ndị ọzọ.
Ịkwalite ahụike na mgbake: Nlekọta kwa ụbọchị maka ndị ọrịa leukemia
Ịhụ na ahụmihe ọgwụgwọ dị mma ma dị ntụsara ahụ maka ndị ọrịa leukemia gụnyere nlekọta kwa ụbọchị nke ọma, gụnyere ịdị ọcha gburugburu ebe obibi, ịdị ọcha onwe onye, nri na-edozi ahụ, na mmega ahụ kwesịrị ekwesị. Ntuziaka a na-enye ndụmọdụ dị mkpa maka nlekọta dị irè kwa ụbọchị iji kwado mgbake.
Nsonaazụ mgbawa nke CD7-Ezubere iche maka CAR-T ọgwụgwọ maka T-ALL na T-LBL
Nnyocha e mere n'oge na-adịbeghị anya na-akọwapụta nsonaazụ na-ekwe nkwa nke CD7-ezubere iche maka ọgwụgwọ antigen receptor (CAR) T cell n'ịgwọ ndị ọrịa nwere nnukwu lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL).
Mkpuchi nke Nzukọ Kwa Afọ 2024 ASH na ngosi
Nzukọ Kwa Afọ nke 66 nke American Society of Hematology (ASH) ga-enwe site na December 7-10, 2024, na San Diego Convention Center, na-egosi nyocha na ọganihu dị elu na hematology.
Olileanya ọhụrụ na ọgwụgwọ ọrịa kansa: Ọgwụgwọ TIL na-apụta dị ka ihu na-esote
N'agbanyeghị ihe ịma aka na-aga n'ihu na mmepụta ihe na ịzụ ahịa, a na-edozi njedebe ọgwụgwọ CAR-T site na ụzọ ọhụrụ na-ekwe nkwa: ọgwụgwọ Tumor-Infiltrating Lymphocyte (TIL). Ọganihu a na-akpọsa oge ọhụrụ n'ọgụ megide etuto siri ike.
Usoro ọgwụgwọ cellular ọ bụ ọdịnihu nke ọrịa autoimmune?
Ngwọta mgbanwe maka ọrịa cancer nwekwara ike ịgwọ ma tọgharịa usoro ahụ ji alụso ọrịa ọgụ iji nye mgbaghara ogologo oge ma ọ bụ ikekwe ọbụna gwọọ ụfọdụ ọrịa autoimmune.
